Natco SMA drug controversy

Latest Post

Bristol Myers Squibb Raises 2026 Revenue Forecast as Newer Drugs Drive Q3 Growth Laurus Labs to Acquire 60% Stake in Canadian Biotech Firm Galenvs Sciences for $3.75 Million Fortis Healthcare Acquires Suguna Hospital in Bengaluru for ₹277 Crore Ro Launches Robin AI Health Agent to Personalise Medication and Patient Care Recommendations Laurus Labs Q2 Results: Net Profit Surges 126% to ₹441 Crore as Revenue Grows 33%

Natco Generic Risdiplam: Kerala Label Row Explained

October 23, 2026 Simone Lamb

The Natco generic risdiplam row in Kerala spans labels, approval status and price: ₹15,900 a bottle versus ₹6.2 lakh for the branded drug.

You missed

Bristol Myers Squibb Raises 2026 Revenue Forecast as Newer Drugs Drive Q3 Growth

October 30, 2026 Simone Lamb

Laurus Labs to Acquire 60% Stake in Canadian Biotech Firm Galenvs Sciences for $3.75 Million

October 30, 2026 Simone Lamb

Healthcare Services

Fortis Healthcare Acquires Suguna Hospital in Bengaluru for ₹277 Crore

October 30, 2026 Simone Lamb

Ro Launches Robin AI Health Agent to Personalise Medication and Patient Care Recommendations

October 30, 2026 Simone Lamb